Table 2.
FMD β(SE) |
|||
---|---|---|---|
Model 1 | Model 2 | Model 3 | |
E1 | 0.60 (0.36) | 0.69 (0.35)a | 0.77 (0.37)a |
E2 | 0.06 (0.15) | 0.11 (0.15) | 0.14 (0.16) |
T | 0.15 (0.69) | –0.08 (0.65) | –0.05 (0.67) |
SHBG | 1.27 (0.36)b | 1.12 (0.36)c | 1.31 (0.40)c |
FTd | −1.41 (0.47)c | −1.42 (0.47)c | −1.58 (0.52)c |
Hormones log-transformed. Model 1: unadjusted. Model 2: baseline lumen diameter, age, race, BMI, leisure time physical activity, β-agonist meds, parity, and anxiety. Model 3: Model 2 plus education, SBP, HOMA, LDL-C, triglycerides, lipid-lowering medications, blood pressure-lowering medications, and diabetes medications.
Abbreviation: SBP, systolic blood pressure.
P < 0.05.
P < 0.001.
P < 0.01.
FT estimated using ensemble allostery models.